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Introduction {#s1}
============

The prevalence of obesity has increased dramatically during the last three decades with 35 percent of the US adult population having a body mass index (BMI) of 30 kg/m^2^ or greater [@pone.0106420-Ogden1]. While obesity is recognized as a significant risk factor for type II diabetes, hypertension, and cardiovascular disease, it is also a significant contributing factor to the pathogenesis of pulmonary diseases such as asthma, obstructive sleep apnea, chronic obstructive pulmonary disease (chronic bronchitis), and a greater severity of illness and death due to influenza H1N1 [@pone.0106420-Cecere1]--[@pone.0106420-Mancuso1].

The death toll from the H1N1 pandemic of 2009 has been estimated to be more than 284,000 worldwide [@pone.0106420-Dawood1]. Although the majority of cases were relatively mild and self-limiting, the severity of illness and mortality were greater among the 30--50 age group [@pone.0106420-Singanayagam1]. In particular, the obese were disproportionately represented among influenza-associated hospitalizations and deaths [@pone.0106420-LaRussa1]. This association between obesity and severity of illness and death from H1N1 influenza has been confirmed by many other reports [@pone.0106420-Centers1]--[@pone.0106420-Jain1]. Furthermore, it appears that obesity is a risk factor for severity of illness from other strains of influenza and viral pathogens known to infect the respiratory tract [@pone.0106420-OBrien1], [@pone.0106420-Akiyama1]. Importantly, the ability of obesity to diminish host defense against influenza infections has been confirmed in robust and carefully controlled studies using obese mice challenged with the pandemic H1N1 and H3N2 strains of the influenza virus [@pone.0106420-OBrien1], [@pone.0106420-Easterbrook1], [@pone.0106420-Smith1]. Whether or not obesity is associated with a greater severity of illness with bacterial pneumonia is less certain [@pone.0106420-Mancuso1], [@pone.0106420-Phung1].

Previously, we reported that obese leptin-deficient *ob/ob* mice exhibited greater mortality following an intratracheal challenge with either *K. pneumoniae* or *S.pneumoniae* [@pone.0106420-Mancuso2], [@pone.0106420-Hsu1]. In these studies, greater mortality in the *ob/ob* mouse was associated with impaired pulmonary bacterial clearance and attenuated alveolar macrophage and neutrophil phagocytosis and killing of bacteria, and the elaboration of reactive oxygen intermediates [@pone.0106420-Moore1]. In addition, many other reports have demonstrated that *ob/ob* mice exhibit host defense defects in response to several other bacterial, mycobacterial, amoeba, and fungal infections [@pone.0106420-Ikejima1]--[@pone.0106420-FernandezRiejos1]. However, leptin deficiency disables host defense, in the absence of obesity, and has been demonstrated to restore antimicrobial functions in the presence of obesity in *ob/ob* mice [@pone.0106420-Hsu1], [@pone.0106420-Mancuso3]. The effect of obesity on host defense against community-acquired pneumonia in humans is controversial and appropriate animal models have not been used to address this important question [@pone.0106420-Phung1]. In the current study, we compared the responses of lean wild type (WT) and obese CPE*^fat/fat^* mice, which lack a functional carboxypeptidase enzyme, following an intratracheal infection with *Streptococcus pneumoniae*, the most common cause of community-acquired pneumonia [@pone.0106420-Bartlett1].

Materials and Methods {#s2}
=====================

Ethics statement {#s2a}
----------------

All animals were treated according to National Institutes of Health guidelines for the use of experimental animals with the approval of the University of Michigan Committee for the Use and Care of Animals (Protocol Number: \#PRO00003932).

Animals {#s2b}
-------

Female CPE*^fat/fat^* mice, bred on a C57BL/6 background and age-matched, female C57BL/6 wild type (WT) animals, were purchased from The Jackson Laboratory, Bar Harbor, ME. All mice were 16--18 weeks of age prior to their use in all the experiments performed for these studies. All mice were maintained in the University of Michigan Unit for Laboratory Animal Medicine, maintained on Formulab 5008 rodent chow (LabDiet, Brentwood, MO).

Murine model of pneumococcal pneumonia {#s2c}
--------------------------------------

*S. pneumoniae* serotype 3, 6303 (American Type Culture Collection, Manassas, VA) was grown to mid-log phase in Todd-Hewett broth, washed in PBS, and serially diluted in sterile saline. Following anesthesia with ketamine (80 mg/kg) and xylazine (10 mg/kg) delivered via an intraperitoneal injection, a midline incision was made to expose the trachea, a 30-µl inoculum containing 50,000 CFU *S*. ***pneumoniae*** was administered via the trachea using a 26-gauge needle, and the wound was closed using surgical glue (Vetbond, 3 M, St. Paul, MN) [@pone.0106420-Mancuso4]. Following infection, mice were warmed by placing their cage on a heating pad and closely observed every 10 min until they recovered from the anesthesia. For the duration of the lethality study, they were observed for survival every 4 hours during the day. Moribund animals (i.e. staggered gate, ruffled fur, unable to reach water or food) were euthanized by CO2 asphyxiation to ameliorate suffering. In a separate group of mice, bacterial growth in lung and spleen homogenates was determined 24 and 48 h after infection using serial dilutions plated on blood agar as previously described [@pone.0106420-Mancuso3].

Lung bronchoalveolar lavage fluid (BALF) and blood cytokine determinations {#s2d}
--------------------------------------------------------------------------

BALF and blood obtained from mice 24 and 48 h after pneumococcal infection were evaluated for GM-CSF(blood only), IL-1β, IL-6, IL-10, IL-12 p70, MIP-2, MCP-1, and TNF-α by ELISA (R&D Duoset, R&D Systems) performed by the University of Michigan Cancer Center Cellular Immunology Core as previously described [@pone.0106420-Phipps1]. Leptin levels (blood only) were determined according to the manufacturer\'s instructions using a commercially available ELISA kit (Millipore, St. Charles, MO).

Blood glucose, serum triglycerides, and leukocyte determinations {#s2e}
----------------------------------------------------------------

Blood was obtained from mice by cardiac puncture following euthanasia by an overdose of CO~2~ for glucose measurements and leukocyte counts. Blood glucose was assessed at baseline using a glucometer (Glucometer Elite; Bayer, Elkhart, IN). Serum triglyceride levels were measured using the GPO kit from Raichem (Clinica Corp., San Marcos, CA), with glycerol as a standard according to the manufacturer\'s instructions. Leukocyte counts were performed after red blood cell lysis (Unopette Microcollection System; Becton-Dickson, Rutherford, NJ) and a Hemavet cell analyzer (Drew Scientific) operated by the University of Michigan Unit for Laboratory Animal Medicine Animal Diagnostic Laboratory.

Statistical analyses {#s2f}
--------------------

Statistical analyses were conducted using Prism 6.0 software (GraphPad Software, La Jolla, CA). Survival differences were assessed using the Mantel-Cox log-rank test. Where appropriate, mean values were compared using a Student *t*-test. Differences were considered significant if *P*≤0.05. All experiments were performed at least three separate times unless otherwise noted in the figure legend. Data are presented as mean values ± standard error of the mean unless noted otherwise.

Results {#s3}
=======

Obesity and metabolic abnormalities in CPE*^fat/fat^* mice {#s3a}
----------------------------------------------------------

In CPE*^fat/fat^* mice, the obese phenotype arises from the lack of carboxypeptidase E, an enzyme that plays an essential role in processing prohormones and proneuropeptides known to regulate appetite and energy expenditure [@pone.0106420-Naggert1]--[@pone.0106420-Johnston1]. As a consequence of the absence of carboxypeptidase, CPE*^fat/fat^* mice exhibit hyperphasia, reduced locomotor activity, and reduced energy expenditure compared with wild type animals [@pone.0106420-Cawley1]. As shown in [Figure 1](#pone-0106420-g001){ref-type="fig"}, the body weights of CPE*^fat/fat^* mice were 2-fold greater than that of WT animals and the increased body mass has previously been attributed to greater fat mass [@pone.0106420-Cawley1]. In addition, the CPE*^fat/fat^* mice were hyperglycemic at 16 wks of age and had substantially higher levels of leptin and serum ([Figure 1B, C and D](#pone-0106420-g001){ref-type="fig"}). Interestingly, we also observed greater total white blood cell (WBC) and neutrophil (PMN) counts in CPE*^fat/fat^* mice ([Figure 1E](#pone-0106420-g001){ref-type="fig"}). In total, the CPE*^fat/fat^* mouse is obese and hyperglycemic with elevated triglycerides, leptin, and peripheral WBC and PMN counts when maintained on a normal chow diet at 16 wks of age.

![Body weight (A), blood glucose (B), serum leptin (C), triglycerides (D), and white blood cell counts (E) in 16-wk-old female wild type (WT) and carboxypeptidase E *^fat/fat^* (CPE*^fat/fat^*) mice at baseline.\
\*,\<0.05 vs WT using student\'s *t*-test. N = 4 mice per group (A-D) and N = 10 mice per group (E).](pone.0106420.g001){#pone-0106420-g001}

Differences in weight loss but not survival or bacterial burdens in WT and CPE*^fat/fat^* mice following intratracheal *S. pneumoniae* infection {#s3b}
------------------------------------------------------------------------------------------------------------------------------------------------

Since the risk of community-acquired pneumonia among obese individuals in clinical and epidemiologic studies is uncertain [@pone.0106420-Mancuso1], we assessed survival and weight loss in WT and CPE*^fat/fat^* mice following *S. pneumonia* challenge. As shown in [Figure 2](#pone-0106420-g002){ref-type="fig"}, the differences between WT and CPE*^fat/fat^* mice in survival were modest and did not reach statistical significance (p = 0.37). However, we did find greater absolute weight loss after infection in CPE*^fat/fat^* mice at both 24 and 48 h post-infection ([Figure 2B](#pone-0106420-g002){ref-type="fig"}). In contrast, we did not find differences in % weight loss (from baseline) post-infection (data not shown). Since differences in survival may not reflect potential differences in host defense, we also examined lung and spleen bacterial burdens after infection. As shown in [Figure 3](#pone-0106420-g003){ref-type="fig"}, pulmonary and spleen bacterial loads were not different between WT and CPE*^fat/fat^* mice at 24 or 48 h after *S. pneumoniae* challenge. Based on these results, CPE*^fat/fat^* did not exhibit impairments in survival or pulmonary clearance of *S. pneumoniae.*

![Survival of WT and CPE*^fat/fat^* mice following *S. pneumoniae* infection (A). Body weight loss, expressed as total weight loss, 24 and 48 h post-infection (B).\
Mice were infected with 5×10^4^ CFUs of *S. pneumonia* via the intratracheal route and monitored for survival for 10 days. N = 6--9 mice per group from 2 independent experiments. Survival was evaluated using the log-rank test. \*, *p*\<0.05, total weight loss for WT vs CPE*^fat/fat^* mice post-infection using a student\'s *t*-test, n = 5 (24 h) and 15 (48 h) mice per group.](pone.0106420.g002){#pone-0106420-g002}

![Bacterial burdens in WT and CPE*^fat/fat^* mice 24 (A) and 48 h (B) following *S. pneumoniae* challenge.\
Mice were infected with 5×10^4^ CFUs of *S. pneumoniae* via the intratracheal route and bacterial loads in tissue homogenates were determined by enumerating CFUs as described in the [*Materials and Methods*](#s2){ref-type="sec"} section. Statistical comparisons were performed using the students *t*-test. n = 5 (24 h) and 15 (48 h) mice per group.](pone.0106420.g003){#pone-0106420-g003}

Effect of *S. pneumonia*e challenge on cytokines in BALF {#s3c}
--------------------------------------------------------

Excess adipose tissue has been shown to produce cytokines that significantly contribute to a chronic state of low-grade systemic inflammation in obese humans and animals [@pone.0106420-Xu1]. Whether or not pulmonary cytokine production is differentially regulated in CPE*^fat/fat^* mice during pneumococcal pneumonia has not been evaluated. Cytokine levels at baseline in BALF were below the limit of detection (data not shown). As shown in [Figure 4](#pone-0106420-g004){ref-type="fig"}, higher levels of TNF-α were observed in the BALF of CPE*^fat/fat^* mice with modestly elevated levels of IL-6, IL-10, IL-12, and MIP-2 that did not reach statistical significance 24 h after infection. In contrast, IL-10 and IL-12 levels were lower in CPE*^fat/fat^* mice 48 h post-infection. As was observed at 24 h, IL-6 was elevated in CPE*^fat/fat^* mice 48 h post-infection but this difference was not statistically significant. In total, there were modest differences between WT and CPE*^fat/fat^* mice in pulmonary cytokines following *S. pneumoniae* challenge.

![Cytokines in bronchoalveolar lavage fluid (BALF) from WT and CPE*^fat/fat^* mice 24 (A) and 48 h (B) post-infection.\
Mice were challenged with 5×10^4^ CFUs of *S. pneumoniae* via the intratracheal route and BALF was obtained 24 and 48 h post- infection and cytokine levels were determined as described in the [*Materials and Methods*](#s2){ref-type="sec"} section. n = 5--7 mice per group. \*, *p\<0.05* vs WT using a student\'s *t*-test.](pone.0106420.g004){#pone-0106420-g004}

Impact of obesity on the systemic inflammatory response following *S. pneumoniae* challenge {#s3d}
-------------------------------------------------------------------------------------------

Since the elevated levels of systemic proinflammatory cytokines (MCP-1, IL-1β, and IL-6) and increased peripheral blood leukocyte counts have been reported in obese humans and CPE*^fat/fat^* mice, we assessed these cytokines in serum and peripheral blood leukocyte counts after infection [@pone.0106420-Johnston1], [@pone.0106420-Herishanu1]. Although there was a trend for elevated levels of IL-1β, IL-6, and MCP-1 in CPE*^fat/fat^* mice 24 h post infection, none of these differences reached statistically significance ([Figure 5A](#pone-0106420-g005){ref-type="fig"}). In addition, we did not observe differences in blood GM-CSF (data not shown). In contrast, 48 h after infection, we observed a non-significant trend for higher levels of all cytokines in WT animals which was consistent with the trend for elevated spleen bacterial counts (non-significant trend) in WT mice at this time point ([Figure 5B](#pone-0106420-g005){ref-type="fig"}). PMN counts were elevated in CPE*^fat/fat^* mice 48 h after infection. ([Figure 5C](#pone-0106420-g005){ref-type="fig"}). In total, we observed elevated PMN counts in the CPE*^fat/fat^* mice with no differences in peripheral blood cytokines during pneumococcal pneumonia.

![Serum cytokines (A and B) and peripheral blood cell counts (C) in WT and CPE*^fat/fat^* mice following *S. pneumoniae* challenge.\
WT and CPE*^fat/fat^* mice were challenged with 10^5^ CFUs of *S. pneumoniae* via the intratracheal route and serum was prepared from blood samples obtained 24 and 48 h post-infection as mentioned in the [*Materials and Methods*](#s2){ref-type="sec"} section. n = 5--7 mice per group \*, *p*\<0.05 vs WT using a student\'s *t*-test.](pone.0106420.g005){#pone-0106420-g005}

Discussion {#s4}
==========

Obese humans and mice are known to experience a greater severity of illness and death from influenza pneumonia [@pone.0106420-Singanayagam1], [@pone.0106420-OBrien1], [@pone.0106420-Easterbrook1], [@pone.0106420-Smith1], [@pone.0106420-Morgan1], [@pone.0106420-Paich1]. In this report, we compared the responses of lean and obese CPE*^fat/fat^* mice following an intratracheal challenge with *S. pneumoniae*. Despite severe obesity, hyperglycemia, elevated peripheral blood neutrophil counts, and modest differences in lung cytokines following infection, there were no differences between CPE*^fat/fat^* mice and WT animals in survival or pulmonary and spleen bacterial burdens following *S. pneumoniae* challenge. These results suggest that obesity in the CPE*^fat/fat^* mouse, even in the presence of hyperglycemia, does not impair host defense against pneumococcal pneumonia.

While we did not observe differences in bacterial burdens in obese CPE*^fat/fat^* and WT mice following *S. pneumoniae* challenge, it is possible that pulmonary host defense may be impaired in other models of obesity. CPE*^fat/fat^* mice become hyperphagic due to the lack of functional hormones that regulate food intake [@pone.0106420-Cawley2]. The greater weight loss in the CPE*^fat/fat^* mice was likely due to a reduction in hyperphagia since pneumonia is well known to decrease appetite [@pone.0106420-Mancuso3]. However, the % weight loss from baseline, which was not different, is a better measure of the severity of infection in murine models of bacterial pneumonia. The mean blood glucose level of 16-wk-old CPE*^fat/fat^* mice was approximately 180 mg/dL. Murine diet induced obesity (DIO) is produced by feeding animals a high fat diet (40--60% kcals from fat) for several weeks (usually 10--26 wks) resulting in obesity and diabetes (blood glucose \>200 mg/dL) [@pone.0106420-Surwit1], [@pone.0106420-Hariri1]. DIO mice have been shown to exhibit greater renal bacterial burdens in a model of *S. aureus*-induced sepsis and higher oral bacterial counts following *P. gingivalus* infection [@pone.0106420-Strandberg1]. Diabetes, a common comorbidity of obesity, is a well-known risk factor for pneumococcal infections, and poor glucose control in diabetes is known to increase the risk of pneumococcal pneumonia [@pone.0106420-Seminog1], [@pone.0106420-Rueda1]. Hyperglycemia in type II diabetes is known to compromise host defense against cutaneous infections by impairing wound healing, antimicrobial peptide (LL-37)(cathelicidin) production, and epithelial cell proliferation following tissue injury [@pone.0106420-OBrien1], [@pone.0106420-RivasSantiago1], [@pone.0106420-Cianfarani1]. Therefore, the combination of obesity and diabetes may be required to impair host defense during bacterial pneumonia.

Leukocytosis is frequently observed in obese humans and mice [@pone.0106420-Herishanu1], [@pone.0106420-Louriz1]--[@pone.0106420-Faggioni1]. While having a greater number of peripheral blood leukocytes, such as PMNs known to ingest and killing bacteria, may enhance host defense against bacterial infections, a profound recruitment of these cells to a site of infection may also induce collateral tissue damage that diminishes bacterial clearance [@pone.0106420-Hodgson1]. The elevated PMNs in CPE*^fat/fat^* mice at baseline and after infection did not seem to contribute to differences in bacterial burdens in our study.

Excess adipose tissue may contribute to pulmonary inflammation since levels of systemic cytokines (IL-1β, IL-6, MCP-1, and TNF-α) and acute phase proteins (C-reactive protein and serum amyloid A) are elevated in obese humans and mice [@pone.0106420-Tilg1]. Johnston and co-workers reported enhanced pulmonary inflammatory responses in CPE*^fat/fat^* mice following exposure to ozone that was characterized by increased BAL protein, cytokines (IL-6, KC, MCP-1, and MIP-2), and neutrophil recruitment [@pone.0106420-Johnston1]. In addition, peripheral blood neutrophils and MCP-1 were also elevated in the CPE*^fat/fat^* mice in response to ozone. In our studies, we observed modest increases in TNF-α in BALF at 24 h and elevated peripheral blood neutrophils in CPE*^fat/fat^* mice at baseline and 48 h following an intratracheal challenge with *S.pneumoniae*. While there were trends for increased IL-6, IL-1β, and MCP-1 in CPE*^fat/fat^* mice 24 h after infection, these differences did not reach statistical significance. At 48 h post-infection, the lower levels of IL-10 and IL-12 and trend for reduced TNF-α in CPE*^fat/fat^* mice may have been due to the non-significant trend for lower spleen CFUs. In total, the low-grade inflammatory state observed in the CPE*^fat/fat^* mice did not affect pulmonary host defense or substantially enhance pulmonary, or systemic cytokine production following infection.

In summary, obese CPE*^fat/fat^* mice do not exhibit impairments in host defense against *S. pneumoniae*. These results suggest that obesity, accompanied with modest metabolic abnormalities, does not compromise pulmonary innate immunity against pneumococcal pneumonia.
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